ICAM1 and breast carcinoma: To determine if ICAM1 is a valid target in TNBC and metastasis, we further examined the clinical relevance of ICAM1 expression to patient outcomes by analyzing two independent breast cancer patient cohorts, GSE2505540 and GSE145641.